Delancey Street Partners reposted this
Delancey Street Partners is pleased to announce that we served as exclusive financial advisor to US Pharmacopeia (“USP”) in the acquisition of Stratix Labs Corporation (a USP company). Delancey Street provided buy-side M&A advisory services to USP. This is the second transaction in which Delancey Street provided USP with buy-side advisory services. United States Pharmacopeia is an independent scientific organization that collaborates with the world's top experts in health and science to develop quality standards for medicines, dietary supplements, and food ingredients. Through its resources, standards, advocacy, and education, USP helps ensure the availability of quality medicines, supplements, and foods for billions of people worldwide. Headquartered in Saint Paul, MN, Stratix Labs develops and produces tools that simplify workflows and improve the robustness of microbiological quality controls. Stratix Labs is a supplier of materials that can be further developed into reference materials and standards. Stratix Lab’s innovative microbial preservation technology, which powers its products, will have broad applications across industries relevant to USP, such as pharmaceutical and biopharmaceutical manufacturing, compounded medicines, and foods. Learn More: https://lnkd.in/evzpXbPQ